Screening of GPCR drugs for repurposing in breast cancer

• Autori principali: Noor Mazin Abdulkareem (Autore), Raksha Bhat (Autore), Reid T. Powell (Autore), Soumya Chikermane (Autore), Soham Yande (Autore), Lisa Trinh (Autore), Hala Y. Abdelnasser (Autore), Mantasha Tabassum (Autore), Alexis Ruiz (Autore), Mary Sobieski (Autore), Nghi D. Nguyen (Autore), Jun Hyoung Park (Autore), Camille A. Johnson (Autore), Benny A. Kaipparettu (Autore), Richard A. Bond (Autore), Michael Johnson (Autore), Clifford Stephan (Autore), Meghana V. Trivedi (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Drug repurposing can overcome both substantial costs and the lengthy process of new drug discovery and development in cancer treatment. Some Food and Drug Administration (FDA)-approved drugs have been found to have the potential to be repurposed as anti-cancer drugs. However, the progress is slow du...